RVMD · Revolution Medicines Inc. Common Stock
View on chartInsiders & Stakes
| Third Rock Ventures III, L.P. 10% Owner | ▼ Sell | Open Market | 5,104,130 Shares held | 6/8/2022 | View profile |
| Alexis Borisy Director | ▲ Buy | Grant | 2,340,075 Shares held | 6/18/2026 | View profile |
| Schroeder Thilo Director | ▲ Buy | Open Market | 760,869 Shares held | 12/5/2024 | View profile |
| Stephen Michael Kelsey See Remarks | ▼ Sell | Open Market | 286,307 Shares held | 9/16/2026 | View profile |
| Mark A. Goldsmith See Remarks | ▼ Sell | Open Market | 253,342 Shares held | 9/16/2026 | View profile |
| Margaret A. Horn Chief Operating Officer | ▼ Sell | Open Market | 149,680 Shares held | 9/16/2026 | View profile |
| Jack Anders Chief Financial Officer | ▼ Sell | Open Market | 119,216 Shares held | 9/16/2026 | View profile |
| Xiaolin Wang See Remarks | ▼ Sell | Open Market | 116,063 Shares held | 3/17/2026 | View profile |
| Lin Wei Chief Medical Officer | ▼ Sell | Open Market | 101,366 Shares held | 3/17/2026 | View profile |
| Sandra Horning Director | ▲ Buy | Grant | 97,765 Shares held | 6/18/2026 | View profile |
| Sandler Alan B. Chief Development Officer | ▼ Sell | Open Market | 52,559 Shares held | 9/29/2026 | View profile |
| Jeff Cislini SVP & General Counsel | ▼ Sell | Open Market | 51,776 Shares held | 9/25/2026 | View profile |
| Anthony Mancini See Remarks | ▼ Sell | Open Market | 39,765 Shares held | 9/25/2026 | View profile |
| Exter Neil Director | ▲ Buy | Grant | 28,815 Shares held | 6/16/2022 | View profile |
| Flavia Borellini Director | ▲ Buy | Grant | 26,215 Shares held | 6/18/2026 | View profile |
| Sushil Patel Director | ▼ Sell | Open Market | 21,656 Shares held | 6/29/2026 | View profile |
| SCHMIDT ERIC THOMAS Director | ▲ Buy | Grant | 21,251 Shares held | 6/8/2023 | View profile |
| Weber Barbara Chief Executive Officer | ▼ Sell | Open Market | 13,065 Shares held | 10/8/2024 | View profile |
| Frank Clyburn Chief Executive Officer | ▲ Buy | Grant | 10,929 Shares held | 6/18/2026 | View profile |
| Elizabeth M. Anderson Director | ▼ Sell | Open Market | 4,333 Shares held | 9/22/2026 | View profile |
| Lorence H. Kim Director | ▼ Sell | Open Market | 0 Shares held | 9/8/2026 | View profile |
Transaction History
| Sandler Alan B. | ▲ Buy | Option Exercise | 6,000 | $353K | 9/29/2026 |
| Sandler Alan B. | ▼ Sell | Open Market | 2,200 | $442K | 9/29/2026 |
| Sandler Alan B. | ▼ Sell | Open Market | 1,609 | $325K | 9/29/2026 |
| Sandler Alan B. | ▼ Sell | Open Market | 1,000 | $203K | 9/29/2026 |
| Sandler Alan B. | ▼ Sell | Open Market | 1,199 | $244K | 9/29/2026 |
| Sandler Alan B. | ▼ Sell | Open Market | 301 | $62K | 9/29/2026 |
| Jeff Cislini | ▼ Sell | Open Market | 765 | $159K | 9/25/2026 |
| Anthony Mancini | ▲ Buy | Option Exercise | 3,121 | $105K | 9/25/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 3,121 | $626K | 9/25/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 587 | $117K | 9/24/2026 |
| Elizabeth M. Anderson | ▲ Buy | Option Exercise | 5,070 | $6K | 9/22/2026 |
| Elizabeth M. Anderson | ▼ Sell | Open Market | 910 | $175K | 9/22/2026 |
| Elizabeth M. Anderson | ▼ Sell | Open Market | 4,985 | $960K | 9/22/2026 |
| Elizabeth M. Anderson | ▼ Sell | Open Market | 2,648 | $512K | 9/22/2026 |
| Elizabeth M. Anderson | ▼ Sell | Open Market | 1,500 | $292K | 9/22/2026 |
| Elizabeth M. Anderson | ▼ Sell | Open Market | 100 | $20K | 9/22/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 1,764 | $347K | 9/18/2026 |
| Sandler Alan B. | ▼ Sell | Open Market | 5 | $975 | 9/16/2026 |
| Sandler Alan B. | ▼ Sell | Open Market | 336 | $67K | 9/16/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 27 | $5K | 9/16/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 1,747 | $348K | 9/16/2026 |
| Stephen Michael Kelsey | ▼ Sell | Open Market | 85 | $17K | 9/16/2026 |
| Stephen Michael Kelsey | ▼ Sell | Open Market | 5,484 | $1.1M | 9/16/2026 |
| Margaret A. Horn | ▼ Sell | Open Market | 76 | $15K | 9/16/2026 |
| Margaret A. Horn | ▼ Sell | Open Market | 4,891 | $975K | 9/16/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 213 | $42K | 9/16/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 13,775 | $2.7M | 9/16/2026 |
| Jeff Cislini | ▼ Sell | Open Market | 52 | $10K | 9/16/2026 |
| Jeff Cislini | ▼ Sell | Open Market | 3,314 | $660K | 9/16/2026 |
| Jack Anders | ▼ Sell | Open Market | 61 | $12K | 9/16/2026 |
| Jack Anders | ▼ Sell | Open Market | 3,992 | $796K | 9/16/2026 |
| Stephen Michael Kelsey | ▲ Buy | Option Exercise | 52,500 | $2.2M | 9/11/2026 |
| Stephen Michael Kelsey | ▲ Buy | Option Exercise | 40,031 | $1.6M | 9/11/2026 |
| Stephen Michael Kelsey | ▼ Sell | Open Market | 800 | $159K | 9/11/2026 |
| Stephen Michael Kelsey | ▼ Sell | Open Market | 11,833 | $2.4M | 9/11/2026 |
| Stephen Michael Kelsey | ▼ Sell | Open Market | 13,368 | $2.7M | 9/11/2026 |
| Stephen Michael Kelsey | ▼ Sell | Open Market | 21,447 | $4.3M | 9/11/2026 |
| Stephen Michael Kelsey | ▼ Sell | Open Market | 18,869 | $3.8M | 9/11/2026 |
| Stephen Michael Kelsey | ▼ Sell | Open Market | 17,949 | $3.7M | 9/11/2026 |
| Stephen Michael Kelsey | ▼ Sell | Open Market | 4,995 | $1.0M | 9/11/2026 |
| Stephen Michael Kelsey | ▼ Sell | Open Market | 3,270 | $673K | 9/11/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 1,179 | $243K | 9/10/2026 |
| Anthony Mancini | ▲ Buy | Option Exercise | 9,363 | $315K | 9/10/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 6,019 | $1.2M | 9/10/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 5,530 | $1.1M | 9/10/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 2,420 | $496K | 9/10/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 300 | $62K | 9/10/2026 |
| Lorence H. Kim | ▼ Sell | Open Market | 706 | $146K | 9/8/2026 |
| Lorence H. Kim | ▼ Sell | Open Market | 999 | $207K | 9/8/2026 |
| Lorence H. Kim | ▼ Sell | Open Market | 3,587 | $748K | 9/8/2026 |
| Lorence H. Kim | ▼ Sell | Open Market | 2,853 | $598K | 9/8/2026 |
| Lorence H. Kim | ▼ Sell | Open Market | 4,730 | $996K | 9/8/2026 |
| Lorence H. Kim | ▼ Sell | Open Market | 3,844 | $812K | 9/8/2026 |
| Lorence H. Kim | ▼ Sell | Open Market | 371 | $79K | 9/8/2026 |
| Lorence H. Kim | ▼ Sell | Open Market | 2,128 | $437K | 8/31/2026 |
| Lorence H. Kim | ▼ Sell | Open Market | 625 | $129K | 8/31/2026 |
| Lorence H. Kim | ▼ Sell | Open Market | 300 | $60K | 8/31/2026 |
| Lorence H. Kim | ▼ Sell | Open Market | 6,597 | $1.3M | 8/31/2026 |
| Lorence H. Kim | ▼ Sell | Open Market | 12,919 | $2.6M | 8/31/2026 |
| Lorence H. Kim | ▼ Sell | Open Market | 26,160 | $5.3M | 8/31/2026 |
| Lorence H. Kim | ▼ Sell | Open Market | 7,271 | $1.5M | 8/31/2026 |
| Jeff Cislini | ▲ Buy | Option Exercise | 29,680 | $551K | 8/21/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 126 | $27K | 8/21/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 229 | $48K | 8/21/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 126 | $27K | 8/21/2026 |
| Jeff Cislini | ▲ Buy | Option Exercise | 26,600 | $575K | 8/21/2026 |
| Jeff Cislini | ▼ Sell | Open Market | 3,400 | $705K | 8/21/2026 |
| Jeff Cislini | ▼ Sell | Open Market | 17,323 | $3.6M | 8/21/2026 |
| Jeff Cislini | ▼ Sell | Open Market | 25,817 | $5.4M | 8/21/2026 |
| Jeff Cislini | ▼ Sell | Open Market | 2,540 | $534K | 8/21/2026 |
| Jeff Cislini | ▼ Sell | Open Market | 4,500 | $951K | 8/21/2026 |
| Jeff Cislini | ▼ Sell | Open Market | 3,314 | $703K | 8/21/2026 |
| Mark A. Goldsmith | ▲ Buy | Option Exercise | 80,000 | $378K | 8/21/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 5,128 | $1.1M | 8/21/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 24,917 | $5.2M | 8/21/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 35,938 | $7.5M | 8/21/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 3,813 | $802K | 8/21/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 6,583 | $1.4M | 8/21/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 3,621 | $768K | 8/21/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 190 | $39K | 8/21/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 951 | $198K | 8/21/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 1,351 | $283K | 8/21/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 136 | $29K | 8/21/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 245 | $52K | 8/21/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 127 | $27K | 8/21/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 177 | $37K | 8/21/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 937 | $195K | 8/21/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 1,405 | $294K | 8/21/2026 |
| Sushil Patel | ▼ Sell | Open Market | 600 | $114K | 6/29/2026 |
| Sushil Patel | ▲ Buy | Option Exercise | 2,955 | $111K | 6/29/2026 |
| Sushil Patel | ▼ Sell | Open Market | 300 | $55K | 6/29/2026 |
| Sushil Patel | ▼ Sell | Open Market | 900 | $166K | 6/29/2026 |
| Sushil Patel | ▼ Sell | Open Market | 858 | $160K | 6/29/2026 |
| Sushil Patel | ▼ Sell | Open Market | 300 | $56K | 6/29/2026 |
| Sushil Patel | ▼ Sell | Open Market | 100 | $19K | 6/29/2026 |
| Sushil Patel | ▼ Sell | Open Market | 541 | $104K | 6/29/2026 |
| Sushil Patel | ▼ Sell | Open Market | 881 | $170K | 6/29/2026 |
| Sushil Patel | ▼ Sell | Open Market | 1,100 | $204K | 6/29/2026 |
| Jack Anders | ▲ Buy | Option Exercise | 20,000 | $371K | 6/24/2026 |
| Jack Anders | ▼ Sell | Open Market | 4,553 | $762K | 6/24/2026 |
| Jack Anders | ▼ Sell | Open Market | 9,496 | $1.6M | 6/24/2026 |
| Jack Anders | ▼ Sell | Open Market | 5,651 | $956K | 6/24/2026 |
| Jack Anders | ▼ Sell | Open Market | 300 | $51K | 6/24/2026 |
| Lorence H. Kim | ▲ Buy | Grant | 1,191 | $0 | 6/18/2026 |
| Alexis Borisy | ▲ Buy | Grant | 1,191 | $0 | 6/18/2026 |
| Elizabeth M. Anderson | ▲ Buy | Grant | 1,191 | $0 | 6/18/2026 |
| Sandra Horning | ▲ Buy | Grant | 1,191 | $0 | 6/18/2026 |
| Frank Clyburn | ▲ Buy | Grant | 1,191 | $0 | 6/18/2026 |
| Sushil Patel | ▲ Buy | Grant | 1,191 | $0 | 6/18/2026 |
| Flavia Borellini | ▲ Buy | Grant | 1,191 | $0 | 6/18/2026 |
| Margaret A. Horn | ▼ Sell | Open Market | 29,600 | $4.7M | 6/17/2026 |
| Margaret A. Horn | ▲ Buy | Option Exercise | 573 | $23K | 6/17/2026 |
| Margaret A. Horn | ▲ Buy | Option Exercise | 3,302 | $98K | 6/17/2026 |
| Margaret A. Horn | ▲ Buy | Option Exercise | 25,725 | $682K | 6/17/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 10,020 | $1.6M | 6/16/2026 |
| Jeff Cislini | ▼ Sell | Open Market | 2,157 | $337K | 6/16/2026 |
| Stephen Michael Kelsey | ▼ Sell | Open Market | 4,175 | $652K | 6/16/2026 |
| Jack Anders | ▼ Sell | Open Market | 2,722 | $425K | 6/16/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 4,615 | $720K | 6/16/2026 |
| Margaret A. Horn | ▲ Buy | Option Exercise | 15,546 | $633K | 6/15/2026 |
| Margaret A. Horn | ▲ Buy | Option Exercise | 44,854 | $1.3M | 6/15/2026 |
| Margaret A. Horn | ▼ Sell | Open Market | 60,400 | $9.7M | 6/15/2026 |
| Margaret A. Horn | ▼ Sell | Open Market | 1,800 | $268K | 6/11/2026 |
| Margaret A. Horn | ▼ Sell | Open Market | 1,315 | $190K | 6/11/2026 |
| Margaret A. Horn | ▼ Sell | Open Market | 200 | $30K | 6/11/2026 |
| Margaret A. Horn | ▼ Sell | Open Market | 500 | $74K | 6/11/2026 |
| Margaret A. Horn | ▲ Buy | Option Exercise | 1,094 | $46K | 6/11/2026 |
| Margaret A. Horn | ▼ Sell | Open Market | 885 | $128K | 6/11/2026 |
| Margaret A. Horn | ▼ Sell | Open Market | 700 | $102K | 6/11/2026 |
| Margaret A. Horn | ▼ Sell | Open Market | 4,600 | $688K | 6/11/2026 |
| Margaret A. Horn | ▲ Buy | Option Exercise | 8,906 | $363K | 6/11/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 700 | $107K | 5/26/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 2,000 | $308K | 5/26/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 421 | $65K | 5/26/2026 |
| Anthony Mancini | ▲ Buy | Option Exercise | 3,121 | $105K | 5/26/2026 |
| Anthony Mancini | ▲ Buy | Option Exercise | 3,120 | $105K | 4/27/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 1,671 | $220K | 4/27/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 1,049 | $139K | 4/27/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 400 | $54K | 4/27/2026 |
| Mark A. Goldsmith | ▲ Buy | Option Exercise | 23,244 | $95K | 4/15/2026 |
| Mark A. Goldsmith | ▲ Buy | Option Exercise | 96,756 | $458K | 4/15/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 120,000 | $18.0M | 4/15/2026 |
| Anthony Mancini | ▲ Buy | Option Exercise | 37,450 | $1.3M | 3/25/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 1,800 | $168K | 3/25/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 3,128 | $295K | 3/25/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 21,086 | $2.0M | 3/25/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 11,036 | $1.1M | 3/25/2026 |
| Anthony Mancini | ▼ Sell | Open Market | 400 | $39K | 3/25/2026 |
| Jeff Cislini | ▼ Sell | Open Market | 1,163 | $113K | 3/19/2026 |
| Margaret A. Horn | ▼ Sell | Open Market | 4,583 | $456K | 3/17/2026 |
| Jack Anders | ▼ Sell | Open Market | 2,753 | $274K | 3/17/2026 |
| Jeff Cislini | ▼ Sell | Open Market | 1,795 | $179K | 3/17/2026 |
| Xiaolin Wang | ▼ Sell | Open Market | 2,010 | $200K | 3/17/2026 |
| Lin Wei | ▼ Sell | Open Market | 2,073 | $206K | 3/17/2026 |
| Stephen Michael Kelsey | ▼ Sell | Open Market | 4,302 | $428K | 3/17/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 12,871 | $1.3M | 3/17/2026 |
| Elizabeth M. Anderson | ▼ Sell | Gift | 15,000 | $0 | 3/4/2026 |
| Elizabeth M. Anderson | ▼ Sell | Gift | 15,000 | $0 | 3/4/2026 |
| Mark A. Goldsmith | ▲ Buy | Option Exercise | 30,000 | $123K | 3/2/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 700 | $69K | 3/2/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 3,500 | $349K | 3/2/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 3,620 | $365K | 3/2/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 21,329 | $2.2M | 3/2/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 851 | $87K | 3/2/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 100 | $10K | 3/2/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 400 | $40K | 3/2/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 1,700 | $173K | 3/2/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 800 | $82K | 3/2/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 100 | $10K | 3/2/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 600 | $60K | 3/2/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 2,100 | $213K | 3/2/2026 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 200 | $20K | 3/2/2026 |
| Xiaolin Wang | ▲ Buy | Grant | 15,100 | $0 | 3/1/2026 |
| Lin Wei | ▲ Buy | Grant | 15,100 | $0 | 3/1/2026 |
| Stephen Michael Kelsey | ▲ Buy | Grant | 21,100 | $0 | 3/1/2026 |
| Mark A. Goldsmith | ▲ Buy | Grant | 57,100 | $0 | 3/1/2026 |
| Margaret A. Horn | ▲ Buy | Grant | 21,100 | $0 | 3/1/2026 |
| Jeff Cislini | ▲ Buy | Grant | 14,500 | $0 | 3/1/2026 |
| Jack Anders | ▲ Buy | Grant | 20,200 | $0 | 3/1/2026 |
| Mark A. Goldsmith | ▲ Buy | Option Exercise | 24,010 | $13K | 2/6/2026 |
| Jeff Cislini | ▼ Sell | Open Market | 908 | $105K | 1/21/2026 |
| Margaret A. Horn | ▲ Buy | Option Exercise | 51,406 | $2.2M | 1/7/2026 |
| Margaret A. Horn | ▲ Buy | Option Exercise | 23,594 | $703K | 1/7/2026 |
| Margaret A. Horn | ▼ Sell | Open Market | 53,096 | $5.3M | 1/7/2026 |
| Margaret A. Horn | ▼ Sell | Open Market | 20,204 | $2.1M | 1/7/2026 |
| Jack Anders | ▲ Buy | Option Exercise | 10,000 | $425K | 1/7/2026 |
| Jack Anders | ▼ Sell | Open Market | 10,000 | $980K | 1/7/2026 |
| Margaret A. Horn | ▼ Sell | Open Market | 1,700 | $175K | 1/7/2026 |
| Stephen Michael Kelsey | ▼ Sell | Open Market | 5,447 | $418K | 12/16/2025 |
| Jeff Cislini | ▼ Sell | Open Market | 2,688 | $206K | 12/16/2025 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 15,394 | $1.2M | 12/16/2025 |
| Margaret A. Horn | ▼ Sell | Open Market | 4,847 | $372K | 12/16/2025 |
| Jack Anders | ▼ Sell | Open Market | 3,104 | $239K | 12/16/2025 |
| Jack Anders | ▲ Buy | Option Exercise | 5,418 | $92K | 11/25/2025 |
| Jack Anders | ▼ Sell | Open Market | 5,418 | $401K | 11/25/2025 |
| Mark A. Goldsmith | ▲ Buy | Option Exercise | 60,000 | $245K | 11/25/2025 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 60,000 | $4.5M | 11/25/2025 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 3,000 | $225K | 11/25/2025 |
| Mark A. Goldsmith | ▼ Sell | Open Market | 3,000 | $225K | 11/25/2025 |
| Mark A. Goldsmith | ▲ Buy | Option Exercise | 20,000 | $82K | 11/18/2025 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
RVMD RASONQUE Receives Positive EU CHMP Opinion
The European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion recommending marketing authorization for Revolution Medicines’ RASONQUE (daraxonrasib) in metastatic pancreatic cancer. This development supports the company’s pipeline and may broaden its commercial prospects in Europe. Analysts have maintained their target price, reflecting confidence in the drug’s potential.
RVMD RASONQUE Receives Positive EU CHMP Opinion. The European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion recommending marketing authorization for Revolution Medicines’ RASONQUE (daraxonrasib) in metastatic pancreatic cancer. This development supports the company’s pipeline and may broaden its commercial prospects in Europe. Analysts have maintained their target price, reflecting confidence in the drug’s potential.